Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs SkyWest Inc (SKYW) Price & Performance

AbCellera Biologics IncTrade
SkyWest IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs SkyWest Inc — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while SkyWest Inc trades at $108.98 (market cap $4.19B). The key difference: SkyWest Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals.

ABCLSKYW
Market Cap
$2.99B$4.19B
Sector
HealthTechnology
52-Week High
$9.76$123.72
52-Week Low
$2.78$78.40
Enterprise Value
$2.58B$5.97B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About SkyWest Inc

SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.

Read more on SKYW